Loading institutional data...
Loading institutional data...
Strong institutional distribution: ownership decreased -4.26% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Top 18 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 5 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -21%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 5 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~21.8% on $2M of debt.
Cash of $2M is below short-term debt of $2M — relies on refinancing/operations.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-08-04
No standout strengths flagged.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cost of Revenue | — | — | — | 77.0 | 79.6 |
| Gross Profit | — | — | — | 23.0 | 20.4 |
| R&D | — | — | — | 4.6 | 11.0 |
| SG&A | — | — | — | 354.2 | 651.4 |
| Operating Income | — | — | — | -331.2 | -631.0 |
| Income Tax | — | — | — | -44.3 | -63.0 |
| Net Income | — | — | — | -68.3 | -931.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on OSRHW: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-08-04 · 45d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.9M 100.0% | $3.5M 100.0% | — | — | — |
| Cost of Revenue | $2.3M 79.6% | $2.7M 77.0% | — | — | — |
| Gross Profit | $593K 20.4% | $811K 23.0% | — | — | — |
| Research & Development | $318K 11.0% | $161K 4.6% | — | — | — |
| Selling, General & Admin | $18.9M 651.4% | $12.5M 354.2% | $1.8M | $35K | $3K |
| Operating Income | -$18.3M -631.0% | -$11.7M -331.2% | -$1.8M | -$35K | -$3K |
| Interest Expense | $506K 17.4% | $51K 1.5% | — | — | — |
| Interest & Investment Income | $64K 2.2% | $21K 0.6% | $2.8M | — | — |
| Other Income (Expense), net | — | $1.4M 39.9% | $2.8M | — | — |
| Pretax Income | -$28.9M -994.2% | -$11.9M -336.9% | $945K | — | — |
| Income Tax Expense | -$1.8M -63.0% | -$1.6M -44.3% | $541K | — | — |
| Net Income | -$27.1M -931.2% | -$2.4M -68.3% | $404K | -$35K | -$3K |
| Per Share | |||||
| EPS (Basic) | $-0.92 | $-4.79 | $0.05 | $-0.01 | — |
| EPS (Diluted) | $-0.80 | $-4.79 | $0.05 | $-0.01 | — |
| Weighted Avg Shares (Basic) | 19.5M | 2.2M | 7.7M | 1.5M | — |
| Weighted Avg Shares (Diluted) | 22.6M | 2.2M | 7.7M | 1.5M | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.